It has enhanced intestinal immunity [83], anti-bacterial [158] and antihypertensive activities [159]
The treatment is 50,000 IUs of Vitamin D3 given monthly, and all other supplementation for vitamin D should be discontinued for the month following injection
Do not change, adjust, or discontinue any medications or prescribed treatments without your physician's approval
It is not a GLP-1 receptor agonist, a weight-loss drug, or a substitute for any prescribed medication, and it is not intended to treat obesity, diabetes, or any other condition
CJC-1295, a synthetic analog of growth hormonereleasing hormone (GHRH), was developed in the early 2000s to extend the half-life and activity of natural GHRH fragments for research into growth hormone and IGF-1 pathways